385395-06-2

Upstream product

• 2881-83-6 ethyl 4-methoxybenzoylacetate 
• 5010-38-8 ethyl 5-hydroxy-2-(4-methoxyphenyl)-1-benzofuran-3-carboxylate 
• 402-23-3 1-bromomethyl-3-trifluoromethylbenzene 

Downstream Products

• 1390638-09-1 2-(4-methoxyphenyl)-5-([3-(trifluoromethyl)benzyl]oxy)-1-benzofuran-3-carboxylic acid 

Relevant academic research and scientific papers

Novel 5-substituted benzyloxy-2-arylbenzofuran-3-carboxylic acids as calcium activated chloride channel inhibitors

Transmembrane protein 16A (TMEM16A) channels are recently discovered membrane proteins that functions as a calcium activated chloride channel (CaCC). CaCCs are major regulators of various physiological processes, such as sensory transduction, epithelial secretion, smooth muscle contraction and oocyte fertilization. Thirty novel 5-substituted benzyloxy-2-arylbenzofuran-3- carboxylic acids (B01-B30) were synthesized and evaluated for their TMEM16A inhibitory activity by using short circuit current measurements in Fischer rat thyroid (FRT) cells expressing human TMEM16A. IC50 values were calculated using YFP fluorescence plate reader assay. Final compounds, having free carboxylic group displayed significant inhibition. Eight of the novel compounds B02, B13, B21, B23, B25, B27, B28, B29 exhibit excellent CaCCs inhibition with IC50 value 50 value of 2.8 ± 1.3 μM. None of the tested ester analogs of final benzofuran derivatives displayed TMEM16A/CaCCs inhibition.